Drug Topics
MARCH 21, 2023
Out of an abundance of caution, the infant formula giant has recalled one of their powdered infant formula products because of a potentially dangerous bacteria.
PhRMA
MARCH 21, 2023
The White House’s Office of Science and Technology Policy (OSTP) recently solicited stakeholder feedback on the clinical research infrastructure for emergency clinical trials, for which PhRMA submitted comments. PhRMA shares OSTP’s recognition of the importance of having a clinical trial infrastructure that supports sites that are ready to respond to emergency situations like COVID-19.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MARCH 21, 2023
According to a recent literature review, various factors have contributed to a shift in vaccine demand, such as perceived vaccine efficacy and safety.
PharmaVoice
MARCH 21, 2023
Four academics-turned-executives share what they’ve learned about the pivot point between life sciences academia and entrepreneurship.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MARCH 21, 2023
The 2-dose hepatitis B vaccine was not associated with a higher risk of acute myocardial infarction compared with the 3-dose hepatitis B vaccine series.
Fierce Healthcare
MARCH 21, 2023
Cleveland Clinic, IBM unveil first quantum computer dedicated to biomedical research hlandi Tue, 03/21/2023 - 11:49
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
European Pharmaceutical Review
MARCH 21, 2023
Primary overall survival (OS) analysis results from Kite’s Phase III ZUMA-7 study showed a statistically significant improvement for CAR T-cell therapy Yescarta ® in OS versus historical treatment. Yescarta demonstrated a 2.5-fold increase in patients who were alive at two years and did not experience cancer progression or require the need for additional cancer treatment compared to standard of care (SOC).
Drug Topics
MARCH 21, 2023
Here’s a look back at the cancer drugs that gained FDA approval in the winter of 2023.
Fierce Healthcare
MARCH 21, 2023
DOJ, state AGs drop appeal to UnitedHealth-Change Healthcare deal ruling pminemyer Tue, 03/21/2023 - 17:26
PharmaVoice
MARCH 21, 2023
Although many pharma and biotech companies had deposits at the failed bank, most have reported little to no exposure.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
MARCH 21, 2023
CMS ruling paves way for virtual reality companies to obtain reimbursement from payers fdiamond Tue, 03/21/2023 - 15:53
STAT
MARCH 21, 2023
Pills, patches, implants, and injections — the various forms of hormonal birth control have different formulations and doses of estrogen, progestin, or both. One might think, then, that they may have an unequal influence on breast cancer risk, but a new study in PLOS Medicine on Tuesday suggests that’s not so. The analysis found that most forms of hormonal birth control, regardless of their formulation, seem to confer roughly the same, small increase to breast cancer risk.
Fierce Healthcare
MARCH 21, 2023
Microsoft's Nuance integrates OpenAI's GPT-4 into voice-enabled medical scribe software hlandi Tue, 03/21/2023 - 21:32
STAT
MARCH 21, 2023
The path to payment for virtual reality companies working in health care just became slightly smoother. AppliedVR, a company targeting chronic pain, has become the first digital therapeutic to find an easy way to secure reimbursement from the Centers for Medicare and Medicaid Services. CMS granted AppliedVR a unique code for its flagship product, RelieVRx, and placed it in an existing benefit category: durable medical equipment.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
MARCH 21, 2023
2 health insurance execs make list of the world's 10 most influential CEOs pminemyer Tue, 03/21/2023 - 13:10
STAT
MARCH 21, 2023
The Covid pandemic exacerbated fear and panic regarding the potential for a future bioterrorism agent. As the lab leak theory continues to cause debate, politicians want to be able to tell their constituents that they are solving the problem by adding more oversight to biological research. But if all they are doing is adding more burden, bureaucracy, and box-checking, is it really making anyone more secure?
Drug Store News
MARCH 21, 2023
CHPA also welcomed new board members at its annual meeting in Orlando, Fla.
STAT
MARCH 21, 2023
Patients beginning treatment for opioid addiction often face excruciating withdrawal symptoms. But for people struggling to transition from ultra-potent illicit fentanyl to comparatively weaker addiction medications, help may be on the way. A new federal regulation would make it easier for some patients to begin treatment on significantly higher doses of methadone , a key medicine used to treat opioid use disorder.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The Checkup by Singlecare
MARCH 21, 2023
Maintaining good control of blood sugar levels is important to optimizing health. And for those with diabetes, it’s paramount to avoiding potentially serious complications such as cardiovascular disease, kidney disease, nerve damage, and eye problems. People with diabetes are often prescribed a continuous glucose monitor (CGM) to help monitor blood sugar levels with real-time updates—but it’s possible that people without diabetes could see additional benefits from using one of these devices.
STAT
MARCH 21, 2023
More than 200 civil society and patient advocacy groups are urging the U.K. government to remove the key negotiator working on a free trade agreement with the Indian government because of his previous ties to a major pharmaceutical company. A leaked version of the agreement already sparked concerns last year that the proposed deal would impede the supply of affordable generic medicines in poor countries around the world.
Drug Store News
MARCH 21, 2023
Drug Store News interviewed Brian Owens, Senior Vice President, Commerce Strategy VMLY&R, about how pharmacists can use digital tools to reach more patients to promote healthy behaviors, improve health outcomes and increase the paths of purchase to O
STAT
MARCH 21, 2023
STAT is reporting on the obstacles that prevent many Americans from accessing methadone and buprenorphine , two key medications used to treat opioid use disorder. People and organizations that sometimes make it difficult to access medication can include doctors, methadone clinics, health insurance companies, recovery groups, law enforcement agencies, jails, prisons, drug courts, and labor unions.
Fierce Healthcare
MARCH 21, 2023
Senators say organ procurement organizations' recent spike in recovered pancreata is hard to digest dmuoio Tue, 03/21/2023 - 13:47
STAT
MARCH 21, 2023
A new obesity treatment being developed by Altimmune met goals for weight loss in a mid-stage clinical trial, but the data showed it doesn’t have a leg up on other popular drugs on the market. The drug, called pemvidutide, is part of a growing class of medications that target the GLP-1 receptor, mimicking the effects of a hormone that can help people feel full.
Drug Store News
MARCH 21, 2023
Milklicious candies, which feature a creamy chocolate milk filling packed into the center of a Hershey’s Kiss, are wrapped in light-blue foils adorned with glasses of milk.
Pharmaceutical Technology
MARCH 21, 2023
Cannabidiol is the second most prevalent active ingredient in cannabis (marijuana) and for medical purposes it is derived directly from the hemp plant (which is closely related to marijuana) or made in a laboratory. So far, the FDA has approved just one CBD product, a prescription drug designed to treat seizures associated with Lennox Gastaut syndrome (LGS) [i].
Drug Store News
MARCH 21, 2023
Sales of shaving products, hair removal and hair care are getting a boost from men looking to spruce up for work and social activities.
Fierce Pharma
MARCH 21, 2023
Biopharma industry lobbies for tax breaks related to US-based manufacturing kdunleavy Tue, 03/21/2023 - 11:14
Drug Store News
MARCH 21, 2023
The new suite of beverages features eight flavors across three categories and is available in spring water, sparkling seltzer and shots.
Fierce Pharma
MARCH 21, 2023
Gilead's Yescarta puts pressure on BMS' Breyanzi with overall survival win in large B-cell lymphoma fkansteiner Tue, 03/21/2023 - 11:14
Drug Store News
MARCH 21, 2023
This young company is using data to predict the next big consumer trends in beauty.
Fierce Pharma
MARCH 21, 2023
As approvals roll in, Takeda details pricing strategy for dengue vaccine launch zbecker Tue, 03/21/2023 - 10:40
Fierce Healthcare
MARCH 21, 2023
Medicare Advantage plans could absorb hit from proposed rate change rather than cut benefits, experts say rking Tue, 03/21/2023 - 16:27
Expert insights. Personalized for you.
464 
Let's personalize your content